All Stories

  1. Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients

    Article • Journal of Pain Research, July 2017, Dove Medical Press

    Dr Pamela Landsman-Blumberg, Richard White

  2. Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany

    Article • ClinicoEconomics and Outcomes Research, February 2017, Dove Medical Press

    Dr Pamela Landsman-Blumberg

  3. Relapse Rates and Healthcare Resource use of Therapy Persistent And Non-Persistent Multiple Sclerosis Patients In Germany – A Real World Analysis

    Article • Value in Health, November 2016, Elsevier

    Dr Pamela Landsman-Blumberg

  4. Maintenance Treatment after COPD exacerbation

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2016, Dove Medical Press

    Dr Tasneem Lokhandwala, Dr Pamela Landsman-Blumberg

  5. Use of Joinpoint Regression To Define Phases of Care In Patients With Advanced Melanoma: An Evaluation From Metastatic Diagnosis Until Death

    Article • Value in Health, May 2016, Elsevier

    Dr Pamela Landsman-Blumberg

  6. Mo1094 Project Sonar: Validating a Cost Normalization Methodology in a Community-Based Registry

    Article • Gastroenterology, April 2016, Elsevier

    Dr Pamela Landsman-Blumberg

  7. 824 Project Sonar: Reduction in Cost of Care in an Attributed Cohort of Patients With Crohn's Disease

    Article • Gastroenterology, April 2016, Elsevier

    Dr Pamela Landsman-Blumberg

  8. The Additional Cost Burden of Preexisting Medical Conditions During Pregnancy and Childbirth

    Article • Journal of Women s Health, November 2015, Mary Ann Liebert Inc

    Dr Pamela Landsman-Blumberg

  9. Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany

    Article • Value in Health, November 2015, Elsevier

    Dr Pamela Landsman-Blumberg

  10. Health care Resource Utilization Before and after natalizumab Initiation among multiple Sclerosis Patients in Germany

    Article • Value in Health, May 2015, Elsevier

    Dr Pamela Landsman-Blumberg

  11. The prevalence of complications and healthcare costs during pregnancy

    Article • Journal of Medical Economics, April 2015, Informa Healthcare

    Dr Pamela Landsman-Blumberg

  12. Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents

    Article • Comparative Effectiveness Research, April 2015, Dove Medical Press

    Dr Pamela Landsman-Blumberg

  13. Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents

    Article • Comparative Effectiveness Research, April 2015, Dove Medical Press

    Dr Pamela Landsman-Blumberg

  14. (430) Long-term opioid users with chronic non-cancer pain: differences between patients with and without diagnosed alcohol abuse or dependence

    Article • Journal of Pain, April 2015, Elsevier

    Dr Pamela Landsman-Blumberg

  15. (441) Healthcare utilization and cost differences in chronic non-cancer pain (CNCP) patients treated long-term with long-acting (LAOs), short-acting (SAOs), both, or with opioid therapy

    Article • Journal of Pain, April 2015, Elsevier

    Dr Pamela Landsman-Blumberg

  16. KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis

    Article • Journal of Experimental & Clinical Cancer Research, March 2015, Springer Science + Business Media

    Dr Pamela Landsman-Blumberg

  17. Costs of Newborn Care Following Complications During Pregnancy and Delivery

    Article • Maternal and Child Health Journal, February 2015, Springer Science + Business Media

    Dr Pamela Landsman-Blumberg

  18. Rotavirus vaccination compliance and completion in a Medicaid infant population

    Article • Vaccine, January 2015, Elsevier

    Dr Pamela Landsman-Blumberg

  19. Assessing Balance in Baseline Characteristics Using Different Propensity Adjusted Methods for Bipolar I Mixed Disorder Patients Initiating Asenapine Versus Other Oral Atypical Antipsychotics

    Article • Value in Health, November 2014, Elsevier

    Dr Pamela Landsman-Blumberg

  20. Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor Treatment

    Article • Journal of Managed Care Pharmacy, October 2014, Academy of Managed Care Pharmacy

    Dr Pamela Landsman-Blumberg

  21. Metastatic Colorectal Cancer Treatment Patterns According to Kirsten Rat Sarcoma Viral Oncogene Homolog Genotype in U.S. Community-Based Oncology Practices

    Article • Clinical Colorectal Cancer, September 2014, Elsevier

    Dr Pamela Landsman-Blumberg

  22. Concordance with Recommended Postdischarge Care Guidelines among Children with Food-Induced Anaphylaxis

    Article • The Journal of Pediatrics, June 2014, Elsevier

    Dr Pamela Landsman-Blumberg

  23. The Impact of Maternal Comorbidities on the Cost of Care for Pregnant Women and Newborns

    Article • Journal of Obstetric Gynecologic & Neonatal Nursing, June 2014, Elsevier

    Dr Pamela Landsman-Blumberg

  24. Abstract P3-06-11: Disease and treatment characteristics of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents

    Article • Cancer Research, December 2013, American Association for Cancer Research (AACR)

    Dr Pamela Landsman-Blumberg

  25. Food-induced Anaphylaxis Among Commercially Insured US Adults: Patient Concordance with Postdischarge Care Guidelines

    Article • The Journal of Allergy and Clinical Immunology In Practice, November 2013, Elsevier

    Dr Pamela Landsman-Blumberg

  26. Comparison of Methods to Identify Stage IIIB or IV Metastatic Lung Cancer Patients from Electronic Medical Records

    Article • Value in Health, November 2013, Elsevier

    Dr Pamela Landsman-Blumberg

  27. Using text mining of electronic medical records to identify kras testing status in mcrc patients

    Article • Value in Health, May 2013, Elsevier

    Dr Pamela Landsman-Blumberg

  28. Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population

    Article • Journal of Comparative Effectiveness Research, March 2013, Future Medicine

    Dr Pamela Landsman-Blumberg

  29. Abstract P5-20-12: Aromatase inhibitor failure: predictors and time to first failure among women with metastatic ER+/HER2− breast cancer in the US

    Article • Cancer Research, December 2012, American Association for Cancer Research (AACR)

    Dr Pamela Landsman-Blumberg

  30. Abstract P2-14-07: Evaluation of Aromatase Inhibitor failure and total healthcare expenditures among post-menopausal women with metastatic ER+/HER2− breast cancer in the US

    Article • Cancer Research, December 2012, American Association for Cancer Research (AACR)

    Dr Pamela Landsman-Blumberg

  31. PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer

    Article • Value in Health, June 2012, Elsevier

    Dr Pamela Landsman-Blumberg

  32. PRS45 A Large-Scale Retrospective Study of Emergency Department Visits or Hospitalizations for Anaphylaxis among Patients with Employer- Sponsored Health Insurance

    Article • Value in Health, June 2012, Elsevier

    Dr Pamela Landsman-Blumberg

  33. A Retrospective Database Study of US Children in the Emergency Department or Hospital with Food-induced Anaphylaxis: Concordance with Recommended Post-Discharge Care

    Article • Journal of Allergy and Clinical Immunology, February 2012, Elsevier

    Dr Pamela Landsman-Blumberg

  34. PCN51 Health Care Resources and Costs Across Lines of Therapies in Insured Patients with Metastatic Breast Cancer in the United States

    Article • Value in Health, November 2011, Elsevier

    Dr Pamela Landsman-Blumberg

  35. Healthcare Utilization in Community-Acquired Pneumonia Episodes of Care

    Article • Medical Care, October 2009, Wolters Kluwer Health

    Dr Pamela Landsman-Blumberg

  36. Patient Adherence: Present State and Future Directions

    Article • Disease Management, December 2007, Mary Ann Liebert Inc

    Dr Pamela Landsman-Blumberg

  37. Reassessment of cardiovascular risk in diabetes

    Article • Current Opinion in Lipidology, December 2006, Wolters Kluwer Health

    Dr Pamela Landsman-Blumberg

  38. Metabolic Syndrome and Hyperglycemia: Congruence and Divergence

    Article • The American Journal of Cardiology, October 2006, Elsevier

    Dr Pamela Landsman-Blumberg

  39. Addressing a Treatment Gap

    Article • Clinical Drug Investigation, January 2002, Springer Science + Business Media

    Dr Pamela Landsman-Blumberg

  40. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease

    Article • The American Journal of Cardiology, November 2000, Elsevier

    Dr Pamela Landsman-Blumberg

  41. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system

    Article • Cancer, June 1998, Wiley

    Dr Pamela Landsman-Blumberg

  42. Adverse Drug Events In High Risk Older Outpatients

    Article • Journal of the American Geriatrics Society, August 1997, Wiley

    Dr Pamela Landsman-Blumberg

  43. Inappropriate Prescribing and Health Outcomes in Elderly Veteran Outpatients

    Article • Annals of Pharmacotherapy, May 1997, SAGE Publications

    Dr Pamela Landsman-Blumberg

  44. Inpatient hospital utilization among veterans with traumatic spinal cord injury

    Article • Archives of Physical Medicine and Rehabilitation, October 1996, Elsevier

    Dr Pamela Landsman-Blumberg

  45. Are health-related quality-of-life measures affected by the mode of administration?

    Article • Journal of Clinical Epidemiology, February 1996, Elsevier

    Dr Pamela Landsman-Blumberg